MS4A1 and mature T-cell and NK-cell non-Hodgkin lymphoma: A multicenter retrospective study further confirmed that CD20 positivity is an independent adverse prognostic factor for progression-free survival (PFS) in patients with PTCL-NOS, though it holds no significant predictive value for overall survival (OS) (25).